Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PSNL
SELLPersonalis, Inc. · Healthcare · United States · $1.3B · Avg Vol: $59M/d
24
StockRankGet insider-trade alerts
Q
27
V
25
M
60
P/E (TTM)
—
ROE
-41.4%
D/E
0.2x
Dividend %
—
Loading 1Y...
PRICE (1Y)+24.9%
SMA 50SMA 200
Close
$11.98
RSI (14)
36.5
52W High
$16.39
From 52W High
0.7%
SCORE BREAKDOWN
Quality
27
ROIC
-32.4%22.8
ROE
-41.4%21.4
GP/Assets
2.6%16.0
Op. Margin
-207.9%13.9
FCF/Assets
-25.3%14.2
Piotroski
239.0
Int. Cover
-50.0x6.3
D/E Ratio
0.15x55.8
Current Ratio
6.61x78.7
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-11.2x25.0
P/FCF
—N/A
P/B
4.8x28.5
P/S
19.5x17.5
Div Yield
—N/A
Momentum
60
52W High %
73%59.3
RS 6M
10%81.0
SMA 50/200
1.27x93.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+11%28.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$1.3B
P/E (Forward)
-13.0x
Gross Margin
13.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PSNL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PSNL | Personalis, Inc.(you) | $1.3B | 24 | SELL |
| FRNM | Freenome, Inc. | $1.2B | 11 | STRONG SELL |
| CSTL | Castle Biosciences, Inc. | $749M | 19 | STRONG SELL |
| WGS | GeneDx Holdings Corp. | $1.8B | 14 | STRONG SELL |
| OPK | OPKO Health, Inc. | $921M | 35 | HOLD |
| FLGT | Fulgent Genetics, Inc. | $559M | 27 | SELL |
| GRAL | GRAIL, Inc. | $2.9B | 19 | STRONG SELL |
| NEO | NeoGenomics, Inc. | $1.8B | 45 | HOLD |
| MYGN | Myriad Genetics, Inc. | $530M | 35 | SELL |
| RDNT | RadNet, Inc. | $4.8B | 31 | SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%